Akut Miyokard Enfarktüslü Genç Bayan Hastada Oral Kontraseptif Kullanımı ve Faktör V Leiden Mutasyonunun Birlikteliği

Year 2013, Volume: 4 Issue: 3, 106 - 108, 01.07.2013

Yusuf İzzettin Alihanoğlu İhsan Alur Bekir Serhat Yıldız Fatma Esin Adnan Bilge

https://izlik.org/JA84EW56BP

Abstract

Oral kontraseptif ilaçlar ile kardiyovasküler ve hemostatik sistem
arasında etkileşim olduğu bilinmektedir. Bu olgu sunumunda
kombine oral kontraseptif ilaç alan, göğüs ağrısı ile acil servise
başvuran ve akut yaygın anterior miyokard enfarktüsü tanısı konan 29 yaşında genç bir hasta tartışılmıştır.

Keywords

Oral kontraseptif , miyokard enfarktüsü , acil servis

Acute Myocardial Infarction in a Young Female Patient Using Oral Contraceptives Possessing a Factor V Leiden Mutation

https://izlik.org/JA84EW56BP

Abstract

It is known that there is an interaction between oral contraceptive pills and the cardiovascular-hemostatic system. In this case report, we discuss a 29-year-old female patient, who had been taking oral contraceptive drugs, who was admitted to the emergency department with chest pain. Acute anterior myocardial infarction was diagnosed

Keywords

Oral contraceptives , myocardial infarction , emergency service

References

• Zaman AG, Helft G, Worthley SG, Badimon JJ. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 2000; 149: 251-66. [CrossRef]
• Jones DR, Schmidt RJ, Pickard RT, Foxworthy PS, Eacho PI. Estrogen re- ceptor-mediated repression of human hepatic lipase gene transcription. J Lipid Res 2002; 43: 383-91.
• Rosendaal FR, Van Hylckama Vlieg A, Tanis BC, Helmerhorst FM. Estrogens, progestogens and thrombosis. J Thromb Haemost 2003; 1: 1371-80. [CrossRef]
• Ouyang P, Michos ED, Karas RH. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol 2006; 47: 1741-53. [CrossRef]
• Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-7. [CrossRef]
• Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CR. The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population. Br J Haematol 1997; 98: 353-5. [CrossRef]
• Donmez Y, Kanadasi M, Tanriverdi K, Demir M, Demirtas M, Cayli M, et al. Pro- thrombin 20210GA and factor V Leiden mutations in patients less than 55 years old with myocardial infarction. Jpn Heart J 2004; 45: 505-12. [CrossRef]
• Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997; 90: 1747-50.
• Satiroğlu O, Vural M, Uyar I, Bostan M. Acute anterior myocardial infarction in a young male patient homozygous for the factor V Leiden mutation. Türk Kardiyol Dern Arş - Arch Turk Soc Cardiol 2010; 38: 194-7.
• Akbal E, Koca D, Altınbaş M. A Case of Arterial Embolism in Upper and Lower Extremities in a Patient with Factor V Leiden Mutation and Pseudo- protein S Deficiency. Erciyes Medical Journal 2009; 31: 344-8.
• Başkurt M, Ozkan T, Arat Ozkan A, Gürmen T. Acute myocardial infarction in a young pregnant woman. Anadolu Kardiyol Derg 2010; 10: 285-6. [CrossRef]